Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
New costs require quick yet thoughtful budget tweaks. This section highlights practical adjustments to preserve balance and grow savings.
27,302 articlesAxsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
A new $6,000 senior tax deduction comes with an income-based phase-out that can trim or erase relief for those who wo...
New data from Goldman Sachs shows AI-driven job losses remain concentrated in early-career roles, with Gen Z bearing ...
A bold move reshapes how we think about crypto, mobility, and networks. Noble's acquisition of Helium Mobile could un...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...
Fuel shortages and rolling blackouts push Cuba toward a tipping point as sanctions tighten Venezuelan oil shipments. ...
Bitcoin mining difficulty jumps 15% to a fresh record as hashrate rebounds from winter-storm curtailments, signaling ...
Lending activity in January offered cautious optimism, but analysts say the real test comes in July as the spring mar...
Oscar Health is betting on a 2026 profitability turnaround after a challenging Q4 2025, highlighting AI efficiency, h...
Goldman Sachs trimmed its U.S. growth view as Iran-related tensions threaten more than higher oil prices. The shift s...
Firms are pouring billions into AI while trimming training and support for staff. Experts warn this mismatch risks un...
Rivian faces a pivotal year as it scales both consumer and commercial EVs amid market volatility. This rivian stock p...